苦胆草对博来霉素致大鼠肺纤维化的防治作用
Anti-fibrotic Effect of Kudancao Tablets on Bleomycin-induced Pulmonary Fibrosis in Rats
-
摘要: [摘要]目的 探讨苦胆草对博莱霉素致大鼠肺纤维化的防治作用.方法 健康成年SD大鼠40只(200±20)g随机分为4组:正常对照组(未做处理)、生理盐水组(气管滴入生理盐水)、模型组(气管滴入博莱霉素5 mg/kg)和苦胆草干预组[灌胃给予苦胆草片混悬液0.705 g/(100 g.d),2次/d、共5次,末次给药1 h,气管滴入博莱霉素5 mg/kg].分别于气管内滴注后14 d和28 d处死动物,检测各项指标.采用碱水解法测定肺组织中羟脯氨酸(HYP)含量,HE染色和银染观察肺组织病理变化.结果 与正常对照组和生理盐水组比较,模型组大鼠肺组织HYP含量明显升高(P<0.01);与模型组比较,苦胆草干预组大鼠肺组织HYP含量明显降低(P<0.01);病理检查发现,模型组大鼠肺组织有明显肺纤维化样改变,苦胆草干预组可明显减轻肺纤维化程度.结论 苦胆草能降低博莱霉素致肺纤维化大鼠肺组织羟脯氨酸含量,减轻肺纤维化程度,有望成为防治肺纤维化的候选药物.Abstract: [Abstract]Objective To investigate the anti-fibrotic effect of Kudancao tablets on bleomycin-induced pulmonary fibrosis in rats . Methods Forty healthy adult SD rats(200±20g)were randomly divided into 4 groups: normal control group(without any treatment),normal saline group(intratracheal instillation of normal saline ),model group(intratracheal instillation of 5mg/kg of Bleomycin)and kudancao tablets group(intragastric administration of kudancao tablets suspended in normal saline, 0.705g/(100 g.d),2 times/day and for 5 times, then intratracheal instillation of 5 mg/kg of Bleomycin 1h later ). Rats in all groups were scraficed 14d and 28d after intratracheal instillation. Alkali hydrolysis method was used to detect the HYP content in lung tissues. The pathological changes were observed with HE staining and silver staining. Results Compared with the normal control group and normal saline group, the HYP content in the lung tissues of rats in model group increased significantly(P<0.01). Compared with the model group, the HYP content in the lung tissues of rats in kudancao tablets group decreased significantly(P<0.01). Pathological examination showed that significant fibrotic changes were found in lungs of rats in model group,while the fibrotic changes were ameliorated in lungs of rats in kudancao tablets group. Conclusion Kudancao tablets may decrease the hydroxyproline content in lung tissues, and ameliorate the fibrotic degree of lungs of rats with bleomycin-induced pulmonary fibrosis.
期刊类型引用(8)
1. 张岩,李玉苓,乔梁. ALT正常的慢性HBV感染患者口服核苷(酸)类似物病毒学应答的预测模型建立. 中国医院用药评价与分析. 2025(01): 48-52 . 百度学术
2. 唐红. 聚乙二醇干扰素α-2b治疗ALT正常的低病毒血症慢性HBV感染患者的临床效果. 临床合理用药. 2025(04): 82-85 . 百度学术
3. 杨娟,黄敏. HBeAg/HBeAb双阳性慢性乙型肝炎患者血清HBV RNA的变化及临床转归分析. 四川医学. 2024(06): 650-654 . 百度学术
4. 柯秋莉,梁晓芳,户丹. FQ-PCR检测乙型肝炎病毒DNA与时间分辨免疫荧光法检测乙肝五项在乙肝诊断中的应用价值. 临床医学研究与实践. 2024(23): 110-113 . 百度学术
5. 谢代发,蓝海清. P-selectin、ICAM-1、IL-17A血清表达与慢性乙肝病情程度间关联性及诊断价值. 江西医药. 2024(10): 961-964 . 百度学术
6. 邱艺辉,杨清梅. 乙肝两对半化学发光法联合DNA检验对慢性乙肝诊断、肝功能评估的价值. 中国现代药物应用. 2024(24): 58-62 . 百度学术
7. 李俊利,赵丹,程留奇,冯贞贞,许敏,邢亚萍. 富马酸丙酚替诺福韦对高病毒载量乙肝肝硬化代偿期患者抗病毒疗效、肝功能及肝纤维化血清学指标的影响分析. 航空航天医学杂志. 2023(10): 1222-1224+1233 . 百度学术
8. 李永富. 高敏PCR检测HBV-DNA在慢乙肝低病毒血症患者中的应用价值. 现代诊断与治疗. 2023(22): 3448-3449+3473 . 百度学术
其他类型引用(2)
-

计量
- 文章访问数: 2713
- HTML全文浏览量: 881
- PDF下载量: 182
- 被引次数: 10